25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Acura Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyze Acura Pharmaceuticals Inc together

I guess you are interested in Acura Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Acura Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Acura Pharmaceuticals Inc

I send you an email if I find something interesting about Acura Pharmaceuticals Inc.

1. Quick Overview

1.1. Quick analysis of Acura Pharmaceuticals Inc (30 sec.)










1.2. What can you expect buying and holding a share of Acura Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$0.37
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$0.37
Return On Investment
26,272.0%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.001 - $0.0014
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Acura Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$-1.30 - $0.63
Total Value Per Share
$-1.30 - $0.63

2.2. Growth of Acura Pharmaceuticals Inc (5 min.)




Is Acura Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$178k-$5.8m$6m3,409.6%

How much money is Acura Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$879k-$1.2m$329k37.4%
Net Profit Margin-56.2%-33.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Acura Pharmaceuticals Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Acura Pharmaceuticals Inc?

Welcome investor! Acura Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Acura Pharmaceuticals Inc.

First you should know what it really means to hold a share of Acura Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Acura Pharmaceuticals Inc is $0.0014. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Acura Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Acura Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $0.09 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Acura Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-951.3%-0.01-951.3%-0.02-1,307.3%-0.05-3,330.0%-0.10-6,984.7%
Usd Book Value Change Per Share0.096,568.0%0.096,568.0%-0.02-1,244.6%0.00-217.5%-0.06-3,946.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.096,568.0%0.096,568.0%-0.02-1,244.6%0.00-217.5%-0.06-3,946.3%
Usd Price Per Share0.50-0.50-0.21-0.29-0.91-
Price to Earnings Ratio-37.54--37.54--11.47--11.94--12.50-
Price-to-Total Gains Ratio5.44-5.44--12.05--8.85--2.38-
Price to Book Ratio185.40-185.40--2.35--161.92--72.86-
Price-to-Total Gains Ratio5.44-5.44--12.05--8.85--2.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0014
Number of shares714285
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.090.00
Usd Total Gains Per Share0.090.00
Gains per Quarter (714285 shares)65,679.96-2,175.26
Gains per Year (714285 shares)262,719.84-8,701.05
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102627202627100-8701-8711
205254405254300-17402-17412
307881607881500-26103-26113
40105087910508700-34804-34814
50131359913135900-43505-43515
60157631915763100-52206-52216
70183903918390300-60907-60917
80210175921017500-69608-69618
90236447923644700-78309-78319
100262719826271900-87011-87020

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%2.010.010.09.1%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%2.08.00.020.0%7.015.00.031.8%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.022.00.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%2.08.00.020.0%7.015.00.031.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Acura Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0920.0920%-0.017+119%-0.003+103%-0.055+160%
Book Value Per Share--0.0030.0030%-0.089+3410%-0.043+1684%0.069-96%
Current Ratio--0.7220.7220%0.157+361%0.570+27%5.785-88%
Debt To Asset Ratio--0.7930.7930%4.393-82%2.345-66%1.422-44%
Debt To Equity Ratio--3.8313.8310%-+100%0.766+400%1.374+179%
Dividend Per Share----0%-0%-0%-0%
Eps---0.013-0.0130%-0.018+37%-0.047+250%-0.098+634%
Free Cash Flow Per Share---0.011-0.0110%-0.011-3%-0.032+183%-0.079+602%
Free Cash Flow To Equity Per Share---0.005-0.0050%-0.007+29%-0.016+212%-0.051+864%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.627--------
Intrinsic Value_10Y_min---1.305--------
Intrinsic Value_1Y_max--0.005--------
Intrinsic Value_1Y_min---0.093--------
Intrinsic Value_3Y_max--0.060--------
Intrinsic Value_3Y_min---0.314--------
Intrinsic Value_5Y_max--0.167--------
Intrinsic Value_5Y_min---0.570--------
Market Cap92402.520-35614%33000900.00033000900.0000%13860378.000+138%19256685.168+71%59832611.754-45%
Net Profit Margin---0.562-0.5620%-0.338-40%-2.722+384%-14.645+2504%
Operating Margin----0%-0.2120%-2.4100%-14.2660%
Operating Ratio--1.7771.7770%1.212+47%3.005-41%15.843-89%
Pb Ratio0.519-35614%185.398185.3980%-2.353+101%-161.918+187%-72.861+139%
Pe Ratio-0.105+100%-37.544-37.5440%-11.474-69%-11.941-68%-12.496-67%
Price Per Share0.001-35614%0.5000.5000%0.210+138%0.292+71%0.907-45%
Price To Free Cash Flow Ratio-0.125+100%-44.476-44.4760%-19.277-57%-19.234-57%-17.852-60%
Price To Total Gains Ratio0.015-35614%5.4385.4380%-12.053+322%-8.853+263%-2.378+144%
Quick Ratio--0.3070.3070%0.083+268%0.193+59%8.365-96%
Return On Assets---1.022-1.0220%-0.696-32%-1.242+22%-0.905-11%
Return On Equity---4.938-4.9380%--100%-0.988-80%-1.555-69%
Total Gains Per Share--0.0920.0920%-0.017+119%-0.003+103%-0.055+160%
Usd Book Value--178000.000178000.0000%-5891000.000+3410%-2819600.000+1684%4559000.000-96%
Usd Book Value Change Per Share--0.0920.0920%-0.017+119%-0.003+103%-0.055+160%
Usd Book Value Per Share--0.0030.0030%-0.089+3410%-0.043+1684%0.069-96%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.013-0.0130%-0.018+37%-0.047+250%-0.098+634%
Usd Free Cash Flow---742000.000-742000.0000%-719000.000-3%-2099400.000+183%-5210200.000+602%
Usd Free Cash Flow Per Share---0.011-0.0110%-0.011-3%-0.032+183%-0.079+602%
Usd Free Cash Flow To Equity Per Share---0.005-0.0050%-0.007+29%-0.016+212%-0.051+864%
Usd Market Cap92402.520-35614%33000900.00033000900.0000%13860378.000+138%19256685.168+71%59832611.754-45%
Usd Price Per Share0.001-35614%0.5000.5000%0.210+138%0.292+71%0.907-45%
Usd Profit---879000.000-879000.0000%-1208000.000+37%-3077000.000+250%-6454000.000+634%
Usd Revenue--1563000.0001563000.0000%3570000.000-56%2233200.000-30%2509100.000-38%
Usd Total Gains Per Share--0.0920.0920%-0.017+119%-0.003+103%-0.055+160%
 EOD+2 -6MRQTTM+0 -0YOY+21 -115Y+27 -510Y+19 -13

3.3 Fundamental Score

Let's check the fundamental score of Acura Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.105
Price to Book Ratio (EOD)Between0-10.519
Net Profit Margin (MRQ)Greater than0-0.562
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.307
Current Ratio (MRQ)Greater than10.722
Debt to Asset Ratio (MRQ)Less than10.793
Debt to Equity Ratio (MRQ)Less than13.831
Return on Equity (MRQ)Greater than0.15-4.938
Return on Assets (MRQ)Greater than0.05-1.022
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Acura Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5019.558
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.003
Ma 100Greater thanMa 2000.012
OpenGreater thanClose0.001
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Acura Pharmaceuticals Inc

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc. and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was formerly known as Halsey Drug Co., Inc. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharmaceuticals, Inc. operates as a subsidiary of Abuse Deterrent Pharma, LLC.

Fundamental data was last updated by Penke on 2024-11-01 03:23:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Acura Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Acura Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -56.2% means that $-0.56 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Acura Pharmaceuticals Inc:

  • The MRQ is -56.2%. The company is making a huge loss. -2
  • The TTM is -56.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-56.2%TTM-56.2%0.0%
TTM-56.2%YOY-33.8%-22.4%
TTM-56.2%5Y-272.2%+215.9%
5Y-272.2%10Y-1,464.5%+1,192.3%
4.3.1.2. Return on Assets

Shows how efficient Acura Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Acura Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -102.2% Return on Assets means that Acura Pharmaceuticals Inc generated $-1.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Acura Pharmaceuticals Inc:

  • The MRQ is -102.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -102.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-102.2%TTM-102.2%0.0%
TTM-102.2%YOY-69.6%-32.6%
TTM-102.2%5Y-124.2%+22.0%
5Y-124.2%10Y-90.5%-33.7%
4.3.1.3. Return on Equity

Shows how efficient Acura Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Acura Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -493.8% Return on Equity means Acura Pharmaceuticals Inc generated $-4.94 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Acura Pharmaceuticals Inc:

  • The MRQ is -493.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -493.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-493.8%TTM-493.8%0.0%
TTM-493.8%YOY--493.8%
TTM-493.8%5Y-98.8%-395.1%
5Y-98.8%10Y-155.5%+56.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Acura Pharmaceuticals Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Acura Pharmaceuticals Inc is operating .

  • Measures how much profit Acura Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Acura Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Acura Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-21.2%+21.2%
TTM-5Y-241.0%+241.0%
5Y-241.0%10Y-1,426.6%+1,185.6%
4.3.2.2. Operating Ratio

Measures how efficient Acura Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.78 means that the operating costs are $1.78 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Acura Pharmaceuticals Inc:

  • The MRQ is 1.777. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.777. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.777TTM1.7770.000
TTM1.777YOY1.212+0.564
TTM1.7775Y3.005-1.229
5Y3.00510Y15.843-12.838
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Acura Pharmaceuticals Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Acura Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.72 means the company has $0.72 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Acura Pharmaceuticals Inc:

  • The MRQ is 0.722. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.722. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.722TTM0.7220.000
TTM0.722YOY0.157+0.566
TTM0.7225Y0.570+0.152
5Y0.57010Y5.785-5.215
4.4.3.2. Quick Ratio

Measures if Acura Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Acura Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.31 means the company can pay off $0.31 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Acura Pharmaceuticals Inc:

  • The MRQ is 0.307. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.307. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.307TTM0.3070.000
TTM0.307YOY0.083+0.223
TTM0.3075Y0.193+0.114
5Y0.19310Y8.365-8.172
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Acura Pharmaceuticals Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Acura Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Acura Pharmaceuticals Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.79 means that Acura Pharmaceuticals Inc assets are financed with 79.3% credit (debt) and the remaining percentage (100% - 79.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Acura Pharmaceuticals Inc:

  • The MRQ is 0.793. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.793. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.793TTM0.7930.000
TTM0.793YOY4.393-3.600
TTM0.7935Y2.345-1.552
5Y2.34510Y1.422+0.923
4.5.4.2. Debt to Equity Ratio

Measures if Acura Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Acura Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 383.1% means that company has $3.83 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Acura Pharmaceuticals Inc:

  • The MRQ is 3.831. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.831. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.831TTM3.8310.000
TTM3.831YOY-+3.831
TTM3.8315Y0.766+3.065
5Y0.76610Y1.374-0.608
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Acura Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Acura Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -37.54 means the investor is paying $-37.54 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Acura Pharmaceuticals Inc:

  • The EOD is -0.105. Based on the earnings, the company is expensive. -2
  • The MRQ is -37.544. Based on the earnings, the company is expensive. -2
  • The TTM is -37.544. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.105MRQ-37.544+37.439
MRQ-37.544TTM-37.5440.000
TTM-37.544YOY-11.474-26.070
TTM-37.5445Y-11.941-25.603
5Y-11.94110Y-12.496+0.555
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Acura Pharmaceuticals Inc:

  • The EOD is -0.125. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -44.476. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -44.476. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.125MRQ-44.476+44.351
MRQ-44.476TTM-44.4760.000
TTM-44.476YOY-19.277-25.198
TTM-44.4765Y-19.234-25.242
5Y-19.23410Y-17.852-1.381
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Acura Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 185.40 means the investor is paying $185.40 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Acura Pharmaceuticals Inc:

  • The EOD is 0.519. Based on the equity, the company is cheap. +2
  • The MRQ is 185.398. Based on the equity, the company is expensive. -2
  • The TTM is 185.398. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.519MRQ185.398-184.879
MRQ185.398TTM185.3980.000
TTM185.398YOY-2.353+187.751
TTM185.3985Y-161.918+347.317
5Y-161.91810Y-72.861-89.057
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2017-12-312018-12-312019-12-312020-12-312021-12-31
Total Stockholder Equity -27-3,590-3,617-1,124-4,741-1,150-5,8916,069178



6.2. Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets860
Total Liabilities682
Total Stockholder Equity178
 As reported
Total Liabilities 682
Total Stockholder Equity+ 178
Total Assets = 860

Assets

Total Assets860
Total Current Assets372
Long-term Assets488
Total Current Assets
Cash And Cash Equivalents 65
Net Receivables 158
Other Current Assets 149
Total Current Assets  (as reported)372
Total Current Assets  (calculated)372
+/-0
Long-term Assets
Property Plant Equipment 438
Long-term Assets Other 50
Long-term Assets  (as reported)488
Long-term Assets  (calculated)488
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities515
Long-term Liabilities167
Total Stockholder Equity178
Total Current Liabilities
Accounts payable 192
Other Current Liabilities 52
Total Current Liabilities  (as reported)515
Total Current Liabilities  (calculated)244
+/- 271
Long-term Liabilities
Long term Debt 150
Capital Lease Obligations Min Short Term Debt50
Long-term Liabilities Other 17
Long-term Liabilities  (as reported)167
Long-term Liabilities  (calculated)217
+/- 50
Total Stockholder Equity
Total Stockholder Equity (as reported)178
Total Stockholder Equity (calculated)0
+/- 178
Other
Capital Stock651
Common Stock Shares Outstanding 65,093
Net Debt 85
Net Invested Capital 328
Net Working Capital -143
Property Plant and Equipment Gross 2,506



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
15,209
11,069
19,364
6,622
4,967
1,792
1,619
45,628
42,961
31,917
25,493
37,173
29,054
28,630
16,033
16,961
8,208
4,604
2,152
2,562
1,736
860
8601,7362,5622,1524,6048,20816,96116,03328,63029,05437,17325,49331,91742,96145,6281,6191,7924,9676,62219,36411,06915,209
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
36,129
27,991
27,453
13,231
14,135
5,910
2,566
461
1,178
1,179
372
3721,1791,1784612,5665,91014,13513,23127,45327,99136,12900000000000
       Cash And Cash Equivalents 
697
442
9,211
942
3,103
260
228
31,368
30,398
30,174
24,045
35,685
7,476
12,340
774
2,485
5,181
2,220
91
862
413
65
65413862912,2205,1812,48577412,3407,47635,68524,04530,17430,39831,3682282603,1039429,211442697
       Short-term Investments 
0
0
0
0
0
0
0
0
5,039
0
0
0
19,946
13,733
11,322
10,837
0
0
0
0
0
0
00000010,83711,32213,73319,9460005,03900000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
153
43
500
142
295
23
71
67
34
627
158
158627346771232951425004315300000000000
       Other Current Assets 
545
238
394
401
307
184
239
10,237
2,922
226
270
291
307
629
218
2,055
1,828
346
394
1,144
1,179
149
1491,1791,1443943461,8282,0552186293072912702262,92210,237239184307401394238545
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
1,044
1,063
231
0
1,013
867
2,038
1,691
1,384
557
488
4885571,3841,6912,0388671,01302311,0631,04400000000000
       Property Plant Equipment 
5,332
5,998
5,367
3,394
1,555
1,341
1,145
1,046
1,073
1,160
1,052
1,044
1,052
941
957
1,013
867
679
606
540
484
438
4384845406066798671,0139579411,0521,0441,0521,1601,0731,0461,1451,3411,5553,3945,3675,9985,332
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
135
68
34
0
0
00346813500000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,845
1,638
1,431
1,224
1,017
810
73
0
0738101,0171,2241,4311,6381,84500000000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
11
5
0
0
1,431
1,359
1,085
844
0
50
5008441,0851,3591,43100511000000000000
> Total Liabilities 
68,558
76,505
31,632
58,689
6,052
7,954
39,899
26,908
5,897
2,007
1,152
530
1,424
10,707
10,981
9,061
7,025
4,631
5,769
7,303
7,627
682
6827,6277,3035,7694,6317,0259,06110,98110,7071,4245301,1522,0075,89726,90839,8997,9546,05258,68931,63276,50568,558
   > Total Current Liabilities 
10,704
12,052
6,567
5,892
988
2,922
29,108
22,276
5,897
2,007
1,152
530
1,419
1,107
2,992
3,244
3,487
4,631
1,435
1,074
7,522
515
5157,5221,0741,4354,6313,4873,2442,9921,1071,4195301,1522,0075,89722,27629,1082,9229885,8926,56712,05210,704
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
9,600
1,758
2,320
2,376
2,694
0
0
6,164
0
06,164002,6942,3762,3201,7589,6000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
9,600
1,758
2,320
2,376
2,694
0
0
6,164
0
06,164002,6942,3762,3201,7589,6000000000000000
       Accounts payable 
2,671
2,979
3,119
1,895
0
0
0
0
382
0
0
530
1,407
815
217
674
780
1,642
1,201
822
662
192
1926628221,2011,6427806742178151,4075300038200001,8953,1192,9792,671
       Other Current Liabilities 
6,189
6,505
3,415
3,952
959
341
328
22,276
5,421
2,007
1,152
477
12
292
379
250
331
295
234
252
696
52
52696252234295331250379292124771,1522,0075,42122,2763283419593,9523,4156,5056,189
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
5
9,600
0
5,817
3,538
0
4,334
6,229
105
167
1671056,2294,33403,5385,81709,6005000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
9,600
0
5,430
2,979
0
0
6,000
0
0
006,000002,9795,43009,6000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
-9,600
-1,758
-2,320
-2,376
-2,694
0
0
-6,164
50
50-6,16400-2,694-2,376-2,320-1,758-9,6000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
5
0
0
387
559
0
4,334
229
105
17
171052294,3340559387005000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
231
0
0
0
0
0
0
0
0
000000002310000000000000
> Total Stockholder Equity
0
0
0
0
0
0
0
18,720
37,064
29,910
24,341
36,643
27,630
17,923
5,052
7,900
1,183
-27
-3,617
-4,741
-5,891
178
178-5,891-4,741-3,617-271,1837,9005,05217,92327,63036,64324,34129,91037,06418,7200000000
   Retained Earnings -390,083-389,204-387,996-384,222-380,380-374,698-367,310-362,321-349,112-335,211-325,54300000000000
   Accumulated Other Comprehensive Income 0000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
361,733
362,422
366,533
0
375,157
375,763
380,145
380,395
383,042
383,097
0
0383,097383,042380,395380,145375,763375,1570366,533362,422361,73300000000000
   Treasury Stock0000000000000000000000



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2021-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,563
Cost of Revenue-0
Gross Profit01,563
 
Operating Income (+$)
Gross Profit0
Operating Expense-2,777
Operating Income-1,214-2,777
 
Operating Expense (+$)
Research Development1,524
Selling General Administrative1,253
Selling And Marketing Expenses0
Operating Expense2,7772,777
 
Net Interest Income (+$)
Interest Income0
Interest Expense-200
Other Finance Cost-0
Net Interest Income-200
 
Pretax Income (+$)
Operating Income-1,214
Net Interest Income-200
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-879-1,749
EBIT - interestExpense = -200
-879
-679
Interest Expense200
Earnings Before Interest and Taxes (EBIT)0-679
Earnings Before Interest and Taxes (EBITDA)-679
 
After tax Income (+$)
Income Before Tax-879
Tax Provision-0
Net Income From Continuing Ops-879-879
Net Income-879
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net535200
 

Technical Analysis of Acura Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Acura Pharmaceuticals Inc. The general trend of Acura Pharmaceuticals Inc is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Acura Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Acura Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.0014 < 0.0014 < 0.0014.

The bearish price targets are: 0.001 > 0.001 > 0.001.

Tweet this
Acura Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Acura Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Acura Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Acura Pharmaceuticals Inc. The current macd is -0.00068651.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Acura Pharmaceuticals Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Acura Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Acura Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Acura Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartAcura Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Acura Pharmaceuticals Inc. The current adx is 86.35.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Acura Pharmaceuticals Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Acura Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Acura Pharmaceuticals Inc. The current sar is 0.14431402.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Acura Pharmaceuticals Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Acura Pharmaceuticals Inc. The current rsi is 19.56. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Acura Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartAcura Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Acura Pharmaceuticals Inc. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Acura Pharmaceuticals Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Acura Pharmaceuticals Inc Daily Stochastic Oscillator ChartAcura Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Acura Pharmaceuticals Inc. The current cci is 74.75.

Acura Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartAcura Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Acura Pharmaceuticals Inc. The current cmo is -42.08202631.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Acura Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartAcura Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Acura Pharmaceuticals Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Acura Pharmaceuticals Inc Daily Williams %R ChartAcura Pharmaceuticals Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Acura Pharmaceuticals Inc.

Acura Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Acura Pharmaceuticals Inc. The current atr is 0.00111516.

Acura Pharmaceuticals Inc Daily Average True Range (ATR) ChartAcura Pharmaceuticals Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Acura Pharmaceuticals Inc. The current obv is -185,180.

Acura Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartAcura Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Acura Pharmaceuticals Inc. The current mfi is 100.00.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Acura Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartAcura Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Acura Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-06-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-16MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Acura Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Acura Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5019.558
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.003
Ma 100Greater thanMa 2000.012
OpenGreater thanClose0.001
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Acura Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Acura Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Acura Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Acura Pharmaceuticals Inc

I send you an email if I find something interesting about Acura Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Acura Pharmaceuticals Inc.

Receive notifications about Acura Pharmaceuticals Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.